New pill could cure parasitic skin disease in months
Cure
Not yet recruiting
This study tests two doses of an experimental oral drug, LXE408, against a standard treatment (miltefosine) for localized cutaneous leishmaniasis, a parasitic skin disease. About 250 adults in the Americas will take the medicine for several weeks. The main goal is to see if the s…
Phase 2 • Sponsor: Drugs for Neglected Diseases • Aim: Cure
Last updated Jun 27, 2026 12:29 UTC